Membrane-bound IL-12 and IL-23 serve as potent mucosal adjuvants when co-presented on whole inactivated influenza vaccines

Tailored Vaccines Targeting the Elderly Using Whole Inactivated Influenza Vaccines Bearing Cytokine Immunomodulators

(2013) Tila Khan et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Targeting of HIV-p24 particle-based vaccine into differential skin layers induces distinct arms of the immune responses

(2011) Christelle Liard et al.   VACCINE

A single nasal dose of fms-like tyrosine kinase receptor-3 ligand, but not peritoneal application, enhances nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx

(2010) Satoru Kodama et al.   VACCINE

Cutting Edge: Lung Mucosal Th17-Mediated Responses Induce Polymeric Ig Receptor Expression by the Airway Epithelium and Elevate Secretory IgA Levels

(2009) Z. Jaffar et al.   JOURNAL OF IMMUNOLOGY

Incorporation of membrane-bound, mammalian-derived immunomodulatory proteins into influenza whole virus vaccines boosts immunogenicity and protection against lethal challenge

(2009) Andrew S Herbert et al.   Virology Journal

A Novel Method to Incorporate Bioactive Cytokines as Adjuvants on the Surface of Virus Particles

(2008) Yufang Yang et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: Effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model

(2008) Niels Hagenaars et al.   VACCINE

Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection

(2008) Laura Bungener et al.   VACCINE

Generation of functionally active HIV-1 specific CD8+ CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization

(2008) Igor M. Belyakov et al.   VIROLOGY